In vitro susceptibilities of 176 clinical isolates of Streptococcus pneumoniae to 11 beta-lactams, erythromycin, and tetracycline

Acta Clinica Belgica

Volumn 51, Issue 6, 1996, Pages 377-385

  Vanhoof, R ^a   Carpentier, M ^b   Glupczynski, Y ^c   Gordts, B ^d   Magerman, K ^e   Nyssen, H J ^a   Simon, A ^f   Surmont, I ^g   Van De Vyvere, M ^h   Van Landuyt, H ^d   Van Nimmen, L ⁱ   Van Noyen, R ^j  

^a PASTEUR INSTITUTE OF BRUSSELS   (Belgium)

^b Centre Hospitalier Regional de La Citadelle   (Belgium)

^c CHU Andre Vesale   (Belgium)

^d General Hospital St Jan   (Belgium)

^e VIRGA JESSE HOSPITAL   (Belgium)

^f Laboratoire de Microbiologie   (Belgium)

^g Heilig Hart Ziekenhuis   (Belgium)

^h Stuivenberg General Hospital   (Belgium)

ⁱ City Hospital De Bijloke   (Belgium)

^j IMELDA HOSPITAL   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFONICID; CEFOTAXIME; CEFPODOXIME; CEFPROZIL; CEFUROXIME; CLAVULANIC ACID; ERYTHROMYCIN; IMIPENEM; PENICILLIN G; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; HUMAN; NONHUMAN; STREPTOCOCCUS PNEUMONIAE;

EID: 12644278858     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1080/22953337.1996.11718535     Document Type: Article

References (20)

1. Musher DM. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis.1992; 14: 801-9.
2. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis. 1992; 15: 77-83.
3. Hakenbeck R, Tarpay M, Tomasz A. Multiple changes of penicillin-binding proteins in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980; 17: 364-71.
4. Fenoll A, Bourgon CM, Muñóz R, Vicioso D, Casal J. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic intections in Spain, 1979-1989. Rev Infect Dis. 1991; 13: 56-60.
5. Marton A. Pneumococcal antimicrobial resistance: the problem in Hungary. Clin Infect Dis. 1992; 15: 106-11.
6. Munoz R, Musser JM, Crain M, et al. Geographic distribution of penicillin-resistant clones of Streptococcus pneumoniae: characterization by penicillin-binding protein profile, surface protein A typing, and multilocus enzyme analysis. Clin Infect Dis. 1992; 15: 112-8.
7. Facklam RR, Washington II JA. Streptococcus and related catalase-negative Gram-positive cocci. In: Balows A, Ed. Manual of Clinical Microbiology. Fifth Edition. Washington, D.C.: ASM. 1991: 238-57.
8. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobicaliy; approved standard. NCCLS Document M7-A3. Vol. 13 No. 25, Villanova PA, 1993.
9. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. NCCLS Document M100-S6, Vol. 15 No. 14, Villanova, PA, 1995.
10. Verhaegen J, Glupczynski Y, Verbist L, et al. Capsular types and antibiotic susceptibility of pneumococci isolated from patients in Belgium with serious infections, 1980-1993. Clin Infect Dis. 1995; 20: 1339-45.
11. Ducoffre G. Surveillance van infectieuze aandoeningen door een netwerk van laboratoria voor microbiologie, 1994 + retrospectieve 1983-1993. Rapport van het Instituut voor Hygiene en Epidemiologie. December 1995: 42-6.
12. Poole MD. Otitis media complications and treatment failures: implications of pneumococcal resistance. Pediatr Infect Dis J. 1995; 14: S23-6.
13. Goldstein FW, Garau J. Resistant pneumococci: a renewed threat in respiratory infections. Scand J Infect Dis. 1994; Suppl. 93: 55-62.
14. Marton A, Gulyas M, Munoz R, Tomasz A. Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary. J Infect Dis. 1991; 163: 542-8.
15. Kam KM, Luey KY, Fung SM, Yiu PP, Harden TJ, Cheung MM. Emergence of multiple-antibiotic-resistant Streptococcus pneumoniae in Hong Kong. Antimicrob Agents Chemother. 1995; 39: 2667-70.
16. Mason Jr EO, Kaplan SL. Penicillin-resistant pneumococci in the United States. Pediatr Infect Dis J. 1995; 14: 1017-18.
17. Frémaux A, Sissia G, Rosenbaum M, Géslin P. In vitro activity of cefpirome (HR 810) a new patenteral cephalosporin, against penicillin susceptible and resistant pneumococci. In: Program and Abstracts of the Thirty-second Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim CA 1992. Abstract 1020 p. 280. ASM, Washington D.C.
18. Spangler SK, Jacobs MR, Appelbaum PC. In vitro susceptibilities of 185 penicillin-susceptible and - resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime and cefdinir. Antimicrob Agents Chemother. 1994; 38: 2902-04.
19. Pankuch GA, Jacobs MR, Appelbaum PC. Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci. J Antimicrob Chemother. 1995; 35: 883-8.
20. Pankuch GA, Jacobs MR, Appelbaum PC. Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin and vancomycin by using time-kill methodology. Antimicrob Agents Chemother. 1994; 38: 2065-72.